People

Michael Acker
Nimbus Therapeutics vice president of molecular sciences, with biochemistry, biophysics and structural biology expertise; previously worked at Delphia Therapeutics, MOMA Therapeutics and Novartis.
Roles
Nimbus Therapeutics
CurrentVice President, Molecular Sciences